Iles R K, Lee C L, Oliver R T, Chard T
Department of Reproductive Physiology, St Bartholomew's Hospital Medical College, London, UK.
Clin Endocrinol (Oxf). 1990 Sep;33(3):355-64. doi: 10.1111/j.1365-2265.1990.tb00500.x.
Ectopic-hCG production occurs in approximately 30% of urothelial cancers. However, the clinical features which might be expected to result from elevated hCG levels are rare. We now show that in six of seven metastatic and 20 of 21 localized (Ta-T4) positive hCG bladder cancer patients, only the free beta-subunit of hCG and its respective urinary breakdown product, beta-core, could be detected in clinical samples. Since only intact hCG is biologically active, this explains the discrepancy between biochemical and clinical findings.
约30%的尿路上皮癌会出现异位人绒毛膜促性腺激素(hCG)分泌。然而,因hCG水平升高而可能出现的临床特征却很罕见。我们现在发现,在7例转移性hCG阳性膀胱癌患者中的6例以及21例局限性(Ta-T4期)hCG阳性膀胱癌患者中的20例的临床样本中,仅能检测到hCG的游离β亚基及其相应的尿液降解产物β核心片段。由于只有完整的hCG具有生物活性,这就解释了生化检查结果与临床发现之间的差异。